Exploring DNA methylation profiles in blood samples of canine gastrointestinal lymphoma
PLOS One · 2025
DOI: 10.1371/journal.pone.0339388 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Miyuki Nakamura und 11 weiteren Autor:innen. Beteiligte Einrichtung: KDDI Research, Inc., Saitama, Japan. Hauptthemen laut MEDLINE: DNA Methylation, Lymphoma, Dog Diseases, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Blood-based testing represents a valuable tool for the detection and monitoring of patient conditions in both human and veterinary medicine. When conventional tissue-based diagnosis is challenging, blood-derived measurements allow for minimally invasive testing. Recent studies across mammalian species, particularly in humans, have explored the use of DNA methylation from whole blood, revealing its potential to predict individual mortality and responses to environmental stresses. While it is well recognized that tumor lesions display altered epigenetic modifications across some mammalian species, little is known about how DNA methylation in blood, as an indirect tissue sample, reflects the status of individuals in dogs. In this study, we conducted whole genome bisulfite sequencing using whole blood samples from twenty dogs diagnosed with canine gastrointestinal lymphoma, which is a prevalent disease in dogs. Comparative analysis with non-lymphoma controls identified over one thousand differentially methylated regions (DMRs). To develop practical predictive models, we narrowed down the number of DMRs from the total identified to a feasible set of probes using machine learning, achieving high accuracy (0.8–0.9) in predicting lymphoma cases. Our research underscores the potential of utilizing DNA methylation from whole blood as predictors and establishes a foundational data infrastructure for genome-wide DNA methylation for canine health monitoring for future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- KDDI Research, Inc., Saitama, Japan.
- Research and Development Section, Anicom Specialty Medical Institute Inc., Kanagawa, Japan.
- Data Science Center, Azabu University, Kanagawa, Japan.
- Rhelixa Inc., Tokyo, Japan.
- Department of Veterinary Clinical Sciences, Laboratory of Veterinary Internal Medicine, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan.
- Japan Small Animal Medical Center, Tokorozawa, Saitama, Japan.
ORCID-Profile: Miyuki Nakamura, Nozomu Yokoyama
Zitieren
APA
Nakamura, M., Matsumoto, Y., Nagata, M., Yasuda, K., Yonekawa, K., Muramatsu, S., Goshima, A., Nakaki, R., Yokoyama, N., Nakashima, K., Okumura, M., & Yamazaki, J. (2025). Exploring DNA methylation profiles in blood samples of canine gastrointestinal lymphoma. PLOS One. https://doi.org/10.1371/journal.pone.0339388
Vancouver
Nakamura M, Matsumoto Y, Nagata M, Yasuda K, Yonekawa K, Muramatsu S, et al. Exploring DNA methylation profiles in blood samples of canine gastrointestinal lymphoma. PLOS One. 2025. doi:10.1371/journal.pone.0339388
BibTeX
@article{Nakamura2025,
author = {Nakamura, Miyuki and Matsumoto, Yuki and Nagata, Masatoshi and Yasuda, Keiji and Yonekawa, Kei and Muramatsu, Shigeki and Goshima, Anna and Nakaki, Ryo and Yokoyama, Nozomu and Nakashima, Ko and Okumura, Masahiro and Yamazaki, Jumpei},
title = {Exploring DNA methylation profiles in blood samples of canine gastrointestinal lymphoma},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0339388}
}
EUVIMED